Optimal benefits for hematopoietic stem cell transplantation: A consensus opinion

Richard T. Maziarz, Stephanie Farnia, Patricia Martin, Krishna V. Komanduri

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Variability in transplantation benefits may directly affect outcomes of individuals undergoing autologous or allogeneic hematopoietic stem cell transplantation procedures. The Financial Working Group of the National Marrow Donor Program-sponsored System Capacity Initiative addressed the issue of variable benefits and reviewed multiple transplantation benefit packages from both public and private payer organizations. On completion of the review, a consensus was obtained on defining a recipient benefit package that avoids major coverage gaps that could negatively influence patient outcomes. The recommendation was to encourage adoption of these benefits at a national level by payers, benefit brokers/consultants, and sales teams.

Original languageEnglish (US)
Pages (from-to)1671-1676
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Issue number11
StatePublished - Nov 1 2014


  • Consensus
  • Hematopoietic stem cell transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Optimal benefits for hematopoietic stem cell transplantation: A consensus opinion'. Together they form a unique fingerprint.

Cite this